Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10550105 Pyridazinones as PARP7 inhibitors

Patent 10550105 was granted and assigned to Ribon Therapeutics on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 11 Dec, 2023
Edits made to:
Article (+156 characters)
Article

Patent abstract

The present invention relates to pyridazinones and related compounds which are inhibitors of PARP7 and are useful in the treatment of cancer.

Edits on 5 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11691969 Pyridazinones as PARP7 inhibtors
0
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Edits on 31 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 31 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 31 Mar, 2023
Edits on 27 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Ribon Therapeutics
Ribon Therapeutics
0
Current Assignee
Ribon Therapeutics
Ribon Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105501050
Date of Patent
February 4, 2020
0
Patent Application Number
163971030
Date Filed
April 29, 2019
0
Patent Citations Received
‌
US Patent 10870641 Pyridazinones as PARP7 inhibitors
0
‌
US Patent 11014913 Pyridazinones as PARP7 inhibitors
0
‌
US Patent 11293927 Screening methods for PARP modulators
0
‌
US Patent 11566020 Pyridazinones as PARP7 inhibitors
0
Patent Primary Examiner
‌
Deepak R Rao
0
Edits on 1 Feb, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Feb, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11566020 Pyridazinones as PARP7 inhibitors
0
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Ribon Therapeutics
Ribon Therapeutics
0
Current Assignee
Ribon Therapeutics
Ribon Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105501050
Date of Patent
February 4, 2020
0
Patent Application Number
163971030
Date Filed
April 29, 2019
0
Patent Citations Received
‌
US Patent 10870641 Pyridazinones as PARP7 inhibitors
0
‌
US Patent 11014913 Pyridazinones as PARP7 inhibitors
0
‌
US Patent 11293927 Screening methods for PARP modulators
0
Patent Primary Examiner
‌
Deepak R Rao
0
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 6 Apr, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11293927 Screening methods for PARP modulators
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11014913 Pyridazinones as PARP7 inhibitors
Edits on 8 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10870641 Pyridazinones as PARP7 inhibitors
Edits on 1 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 1 Feb, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10550105 Pyridazinones as PARP7 inhibitors

Infobox
Is a
Patent
Patent
Patent applicant
Ribon Therapeutics
Ribon Therapeutics
Current assignee
Ribon Therapeutics
Ribon Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10550105
Date of patent
February 4, 2020
Patent application number
16397103
Date Filed
April 29, 2019
Patent primary examiner
‌
Deepak R Rao

Find more entities like US Patent 10550105 Pyridazinones as PARP7 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo